XBIT Straddle Strategy

XBIT (XBiotech Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

XBIT (XBiotech Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $76.2M, a beta of 0.86 versus the broader market, a 52-week range of 2.09-3.61, average daily share volume of 33K, a public-listing history dating back to 2015, approximately 92 full-time employees. These structural characteristics shape how XBIT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.86 places XBIT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a straddle on XBIT?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current XBIT snapshot

As of May 15, 2026, spot at $2.46, ATM IV 209.30%, IV rank 42.21%, expected move 60.00%. The straddle on XBIT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this straddle structure on XBIT specifically: XBIT IV at 209.30% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 60.00% (roughly $1.48 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XBIT expiries trade a higher absolute premium for lower per-day decay. Position sizing on XBIT should anchor to the underlying notional of $2.46 per share and to the trader's directional view on XBIT stock.

XBIT straddle setup

The XBIT straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XBIT near $2.46, the first option leg uses a $2.46 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XBIT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XBIT shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$2.46N/A
Buy 1Put$2.46N/A

XBIT straddle risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

XBIT straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on XBIT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use straddle on XBIT

Straddles on XBIT are pure-volatility plays that profit from large moves in either direction; traders typically buy XBIT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

XBIT thesis for this straddle

The market-implied 1-standard-deviation range for XBIT extends from approximately $0.98 on the downside to $3.94 on the upside. A XBIT long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current XBIT IV rank near 42.21% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on XBIT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, XBIT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XBIT-specific events.

XBIT straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XBIT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XBIT alongside the broader basket even when XBIT-specific fundamentals are unchanged. Always rebuild the position from current XBIT chain quotes before placing a trade.

Frequently asked questions

What is a straddle on XBIT?
A straddle on XBIT is the straddle strategy applied to XBIT (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With XBIT stock trading near $2.46, the strikes shown on this page are snapped to the nearest listed XBIT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are XBIT straddle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the XBIT straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 209.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a XBIT straddle?
The breakeven for the XBIT straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current XBIT market-implied 1-standard-deviation expected move is approximately 60.00%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on XBIT?
Straddles on XBIT are pure-volatility plays that profit from large moves in either direction; traders typically buy XBIT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current XBIT implied volatility affect this straddle?
XBIT ATM IV is at 209.30% with IV rank near 42.21%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related XBIT analysis